What's Going On With Definium Therapeutics Stock Tuesday? - Definium Therapeutics (NASDAQ:DFTX)

Definium Therapeutics, Inc. Announces Proposed Public Offering

Definium Therapeutics launches $500M public offering to fund DT120 ODT, a psychedelic-assisted therapeutic for psychiatric and neurological disorders. The capital raise signals biotech-backed psychedelic therapy as an emerging market category for healthcare-focused investors.